Zobrazeno 1 - 10
of 30
pro vyhledávání: '"S Poestlberger"'
Autor:
S Stengl, P Schrenk, P Konstantiniuk, S Poestlberger, A Haid, S. Roka, V Schwendinger, S Taucher
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 4
Autor:
Christoph Tausch, Anton Haid, Roswitha Koeberle-Wuehrer, S. Poestlberger, Dieter Hecke, Otto Riedl, Michael Janauer, S. Roka, P. Konstantiniuk, Peter Schrenk, Roland Reitsamer
Publikováno v:
Breast (Edinburgh, Scotland). 16(5)
Summary Introduction In many countries sentinel node biopsy (SNB) has become the standard of care in breast cancer based on a large number of observational studies but without results from prospective randomized trials. The goal of our study was to e
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 66:S213-S214
Autor:
Herbert Stöger, Guenther G. Steger, Michael Gnant, Peter Dubsky, Robert Königsberg, Hellmut Samonigg, S. Poestlberger, Christian Fesl, Christian Marth, Raimund Jakesz, Vesna Bjelic-Radisic, B. Mlineritsch, Richard Greil, Georg Pfeiler, Michael Seifert, Christian F. Singer
Publikováno v:
Journal of Clinical Oncology. 30:514-514
514 Background: Zoledronic acid (ZOL) improves disease outcome in premenopausal patients with breast cancer (BC), especially in those with low estrogen environment. Obesity is associated with increased estrogen serum levels, which might influence the
Autor:
Christian F. Singer, Michael Gnant, Georg Pfeiler, H. Samonigg, Günther G. Steger, P. Dubsky, Herbert Stöger, Christian Marth, Robert Königsberg, Vesna Bjelic-Radisic, Christian Fesl, Raimund Jakesz, Richard Greil, B. Mlineritsch, Michael Seifert, S. Poestlberger
Publikováno v:
Journal of Clinical Oncology. 29:514-514
514 Background: Aromatase inhibitors (AIs) are effective as adjuvant endocrine treatment in breast cancer (BC) patients. Recently, it has been argued that BMI at BC diagnosis impacts on the efficac...
Autor:
Günther G. Steger, Raimund Jakesz, S. Poestlberger, G. Luschin-Ebengreuth, Richard Greil, Brigitte Mlineritsch, Herbert Stoeger, Michael Gnant, H. Eidtmann, Christian F. Singer
Publikováno v:
Bone. 48:S17
Autor:
B. Mlineritsch, Michael Gnant, Richard Greil, Raimund Jakesz, G. Luschin-Ebengreuth, Holger Eidtmann, Herbert Stoeger, Christian F. Singer, S. Poestlberger, P. Dubsky
Publikováno v:
Journal of Clinical Oncology. 28:533-533
533 Background: The ABCSG-12 trial examined the efficacy of ovarian suppression using goserelin in combination with anastrozole (ANA) or tamoxifen (TAM) ± zoledronic acid (ZOL) in premenopausal patients (pts) with endocrine-responsive breast cancer
Autor:
P. Dubsky, Ernst Kubista, H. Trapl, Richard Greil, S. Poestlberger, B. Mlineritsch, V. Marth, Florian Fitzal, Elisabeth Melbinger, Ferdinand Haslbauer, Günther G. Steger, Josef Thaler, G. Luschin-Ebengreuth, Christian Menzel, Christoph Tausch, D. Manfreda, P. Sevelda, M. Stierer, M. Gnant, W. Schippinger, Raimund Jakesz
Publikováno v:
The Breast. 18:S53
Autor:
B. Mlineritsch, Ernst Kubista, Michael Gnant, Raimund Jakesz, W. Schippinger, G. Luschin-Ebengreuth, S. Poestlberger, Christian Marth, Christian Menzel, Richard Greil
Publikováno v:
Journal of Clinical Oncology. 26:LBA4-LBA4
LBA4 Background: Zoledronic acid (ZOL) has demonstrated antitumor and antimetastatic activity in preclinical and early clinical studies. The Austrian Breast and Colorectal Cancer Study Group Trial 12 (ABCSG-12) examined the efficacy of ovarian suppre
Autor:
O. Riedl, A Haid, S Poestlberger, Konstatiniuk, U. Denison, C. Peters-Engl, D. Hecke, S. Roka, S. Woelff, Peter Schrenk
Publikováno v:
European Journal of Cancer Supplements. 4:115